Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Neoplasm Metastasis 4Lung Neoplasms 4Triple Negative Breast Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Cholangiocarcinoma 2Carcinoma, Non-Small-Cell Lung 2Breast Neoplasms 2Urinary Bladder Neoplasms 1Tertiary Lymphoid Structures 1Sarcoma 1Recurrence 1Rectal Neoplasms 1Nasopharyngeal Carcinoma 1Microsatellite Instability 1Mesothelioma, Malignant 1Mesothelioma 1Melanoma 1Hematologic Neoplasms 1Esophageal Neoplasms 1Colorectal Neoplasms 1Colonic Neoplasms 1Carcinoma, Transitional Cell 1Carcinoma, Squamous Cell 1Camurati-Engelmann Syndrome 1Brain Neoplasms 1Biliary Tract Neoplasms 1Anatomic Stage II Breast Cancer AJCC v8 1

Interventions

tucatinib 1tremelimumab 1trastuzumab biosimilar HLX02 1ribociclib 1pertuzumab 1durvalumab 1bintrafusp alfa protein, human 1Trastuzumab 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Conformal 1PF-05280014 1Ontruzant 1Ogivri 1Immunoglobulin G 1High-Energy Shock Waves 1Fulvestrant 1Docetaxel 1Disulfides 1Carboplatin 12C4 antibody 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Anatomic Stage II Breast Cancer AJCC v8 × bintrafusp alfa protein, human × Clear all
NCT03620201 2024-10-22

M7824 in Treating Patients With Stage II-III HER2 Positive Breast Cancer

M.D. Anderson Cancer Center

Phase 1 Completed
20 enrolled
Breast

Anatomic Stage II Breast Cancer AJCC v8

Data powered by HemOnc (CC BY 4.0) Colophon âš¡